HCA(US:HCA)2025-07-25 11:46Financial Performance - Revenues for Q2 2025 increased by 6.4% to $18.605 billion compared to $17.492 billion in Q2 2024[2] - Net income attributable to HCA Healthcare, Inc. rose by 13.1% to $1.653 billion, or $6.83 per diluted share, up from $1.461 billion, or $5.53 per diluted share in the prior year[2][4] - Adjusted EBITDA for Q2 2025 increased by 8.4% to $3.849 billion compared to $3.550 billion in Q2 2024[3][4] - Revenues for the six months ended June 30, 2025, increased to $36,926 million, up from $34,831 million in 2024, representing a growth of 6.0%[19] - Net income attributable to HCA Healthcare, Inc. for the same period rose to $3,263 million, compared to $3,052 million in 2024, reflecting an increase of 6.9%[19] - Diluted earnings per share increased to $13.28 in 2025 from $11.47 in 2024, marking a growth of 15.8%[19] - The company reported a diluted earnings per share of $6.83 for Q2 2025, compared to $5.53 in Q2 2024, an increase of 23.5%[27] Cash Flow and Debt - Cash flows from operating activities totaled $4.210 billion in Q2 2025, significantly up from $1.971 billion in Q2 2024[6] - Cash and cash equivalents decreased to $939 million at the end of June 2025, down from $1,933 million at the beginning of the period[22] - Net cash provided by operating activities for the six months ended June 30, 2025, was $5,861 million, an increase from $4,440 million in 2024[22] - As of June 30, 2025, total debt stood at $44.483 billion, with cash and cash equivalents of $939 million[6] - Long-term debt, less debt issuance costs, was $39,379 million as of June 30, 2025, compared to $38,333 million at the end of 2024[21] Operational Metrics - Same facility admissions increased by 1.8% and same facility equivalent admissions increased by 1.7% in Q2 2025 compared to the prior year[4] - Total admissions for the six months ended June 30, 2025, were 1,142,422, a 2.4% increase from 1,115,325 in 2024[24] - The number of hospitals operated increased to 191 as of June 30, 2025, compared to 188 in 2024[24] - The average length of stay decreased to 4.726 days in 2025 from 4.802 days in 2024[24] - Outpatient revenues as a percentage of patient revenues increased to 38.4% in 2025, up from 37.9% in 2024[24] Guidance and Projections - The company updated its 2025 revenue guidance to a range of $74.00 to $76.00 billion, up from the previous range of $72.80 to $75.80 billion[11] - The revised net income guidance for 2025 is now $6.11 to $6.48 billion, an increase from the previous range of $5.85 to $6.29 billion[11] - Capital expenditures for 2025, excluding acquisitions, are estimated to be approximately $5.0 billion[11] - The company forecasts revenues for the year ending December 31, 2025, to be between $74 billion and $76 billion[31] - Projected net income attributable to HCA Healthcare, Inc. for 2025 is estimated to be between $6.110 billion and $6.480 billion[31] - Diluted earnings per share for 2025 are expected to range from $25.50 to $27.00[31] - Adjusted EBITDA for 2025 is forecasted to be between $14.700 billion and $15.300 billion[31] - Adjusted EBITDA margin improved to 20.7% in Q2 2025 from 20.3% in Q2 2024[27]